Differences of the in Vivo and in Vitro Metabolism of Imrecoxib in Humans: Formation of Rate-Limiting Aldehyde Intermediate
Drug Metabolism and Disposition - United States
doi 10.1124/dmd.118.081182
Full Text
Open PDFAbstract
Available in full text
Date
July 6, 2018
Authors
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)